felodipine has been researched along with Hyperlipidemias in 4 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open trial, the antihypertensive efficacy of felodipine and its effects on lipid metabolism were investigated in 117 Nordic patients with mild to moderate essential hypertension and hyperlipidaemia." | 5.08 | Effects of felodipine ER, a dihydropyridine calcium antagonist, on blood pressure and serum lipids. ( Degen, A; Lorenz, H; Reuter, MK; Smith, N; Verho, M; Verho, P, 1998) |
| " Further dosage adjustments are made in accordance with a set protocol." | 2.67 | The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. ( Hansson, L; Zanchetti, A, 1994) |
| "Felodipine was withdrawn and the diabetes was controlled before dental treatment was initiated." | 1.33 | Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient. ( Fay, AA; Gapski, R; Satheesh, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miczke, A | 1 |
| Pupek-Musialik, D | 1 |
| Cymerys, M | 1 |
| Bryl, W | 1 |
| Kujawska-Łuczak, M | 1 |
| Bogdański, P | 1 |
| Fay, AA | 1 |
| Satheesh, K | 1 |
| Gapski, R | 1 |
| Hansson, L | 1 |
| Zanchetti, A | 1 |
| Reuter, MK | 1 |
| Lorenz, H | 1 |
| Verho, P | 1 |
| Smith, N | 1 |
| Degen, A | 1 |
| Verho, M | 1 |
3 trials available for felodipine and Hyperlipidemias
| Article | Year |
|---|---|
[The effect of analysed hypotensive drugs on certain metabolic parameters].
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 2; Felodipine; Female; Humans; Hyperlipidemi | 2003 |
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzym | 1994 |
Effects of felodipine ER, a dihydropyridine calcium antagonist, on blood pressure and serum lipids.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Felodipine; Female; | 1998 |
1 other study available for felodipine and Hyperlipidemias
| Article | Year |
|---|---|
Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Anticholesteremic Agents; Calcium Channel Blockers; Denta | 2005 |